Published December 1, 2017 | Version v1
Journal article

Biomimetic matrix fabricated by LMP-1 gene-transduced MC3T3-E1 cells for bone regeneration

  • 1. Department of Orthopedic, Peking University Shenzhen Hospital, Shenzhen (China)
  • 2. Guangdong Provincial Key Laboratory of Orthopedics and Traumatology, The First Affiliate Hospital of Sun Yat-sen University, Guangzhou (China)

Description

Bone healing is regulated by multiple microenvironmental signals provided by the extracellular matrix (ECM). This study aimed to mimic the native osteoinductive microenvironment by developing an ECM using gene-transduced cells. The LIM mineralization protein-1 (LMP-1) gene was transferred to murine pre-osteoblast cells (MC3T3-E1) using lentiviral vectors. Western blotting assay indicated that the MC3T3-E1 cells expressed an increased level of bone morphologic protein-2, -4 and -7 (BMP-2, -4 and -7) after LMP-1 gene transduction. The transduced cells were then seeded into calcined bovine bone scaffolds and cultured for 7, 14, and 21 days to construct ECMs on the scaffolds. The ECM–scaffold composites were then decellularized using the freeze-drying method. Scaffolds without ECM deposition were used as controls. The composites and controls were implanted into critical-sized bone defects created in the distal femurs of New Zealand rabbits. Twelve weeks after the surgery, both microcomputed tomography and histologic results indicated that the 7-day-cell-modified ECM–scaffold composites induced bone regeneration with significantly larger volume, trabecular thickness and connectivity than the controls. However, the 14- and 21-day-cell-modified ECM–scaffold composites triggered sustained inflammation response even at 12 weeks after the surgery and showed less bone ingrowth and integration than their 7-day-cell-modified counterparts. In conclusion, these results highlight the viable gene transfer techniques for manipulating cells in a constructed microenvironment of ECM for bone regeneration. However, the unresolved inflammation relating to the duration of ECM modification needs to be considered. (paper)

Availability note (English)

Available from http://dx.doi.org/10.1088/1758-5090/aa8dd1

Additional details

Identifiers

Publishing Information

Journal Title
Biofabrication (Online)
Journal Volume
9
Journal Issue
4
Journal Page Range
[14 p.]
ISSN
1758-5090

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
51082760
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
CONNECTIVE TISSUE CELLS; FEMUR; INFLAMMATION; PROTEINS; RABBITS; SURGERY; TOMOGRAPHY
Descriptors DEC
ANIMAL CELLS; ANIMALS; BODY; DIAGNOSTIC TECHNIQUES; MAMMALS; MEDICINE; ORGANIC COMPOUNDS; ORGANS; PATHOLOGICAL CHANGES; SKELETON; SOMATIC CELLS; SYMPTOMS; VERTEBRATES